Kineret - 66658-234-28 - (anakinra)

Alphabetical Index


Drug Information of Kineret

Product NDC: 66658-234
Proprietary Name: Kineret
Non Proprietary Name: anakinra
Active Ingredient(s): 100    mg/.67mL & nbsp;   anakinra
Administration Route(s): SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Kineret

Product NDC: 66658-234
Labeler Name: Swedish Orphan Biovitrum AB (publ)
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA103950
Marketing Category: BLA
Start Marketing Date: 20091215

Package Information of Kineret

Package NDC: 66658-234-28
Package Description: 4 CARTON in 1 CASE (66658-234-28) > 7 SYRINGE, GLASS in 1 CARTON (66658-234-07) > .67 mL in 1 SYRINGE, GLASS (66658-234-01)

NDC Information of Kineret

NDC Code 66658-234-28
Proprietary Name Kineret
Package Description 4 CARTON in 1 CASE (66658-234-28) > 7 SYRINGE, GLASS in 1 CARTON (66658-234-07) > .67 mL in 1 SYRINGE, GLASS (66658-234-01)
Product NDC 66658-234
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name anakinra
Dosage Form Name INJECTION, SOLUTION
Route Name SUBCUTANEOUS
Start Marketing Date 20091215
Marketing Category Name BLA
Labeler Name Swedish Orphan Biovitrum AB (publ)
Substance Name ANAKINRA
Strength Number 100
Strength Unit mg/.67mL
Pharmaceutical Classes Interleukin 1 Receptor Antagonists [MoA],Interleukin-1 Receptor Antagonist [EPC]

Complete Information of Kineret


General Information